US Patent 10036050 Cellobiohydrolase variants and polynucleotides encoding same
Patent 10036050 was granted and assigned to Novozymes on July, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+282 characters)
Article
Patent abstract
The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Mark Wogulis0
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
100360500
Date of Patent
July 31, 2018
0Patent Application Number
143671820
Date Filed
December 20, 2012
0Patent Citations Received
Patent Primary Examiner
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10036050 Cellobiohydrolase variants and polynucleotides encoding same
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10036050
Date of patent
July 31, 2018
Patent application number
14367182
Date Filed
December 20, 2012
Patent primary examiner
Find more entities like US Patent 10036050 Cellobiohydrolase variants and polynucleotides encoding same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
